Ten Year Highlights

RS Crores
  FY99 FY00 FY01* FY02** FY03 FY04*** FY05 FY06# FY07^ FY08
Operating Results:
Sales
863 982 1100 1200 1285 1236 1417 1757 2080 2396
Other Income
23 34 19 12 7 9 9 13 26 34
EBITDA
98 128 137 144 162 164 217 300 376 443
EBITDA Margins (%)
11.3 13.0 12.5 12.0 12.6 13.3 15.3 17.1 18.1 18.5
Profit Before Tax (PBT)
52 81 85 82 106 124 176 257 319 384
Taxes
2 4 7 14 14 15 19 30 39 52
Tax Rate (%)
2.9 4.5 8.5 16.6 13.3 12.0 10.8 11.7 12.1 13.4
Profit After Tax (PAT)
50 77 78 64 85 107 156 214 282 333
PAT Margins (%)
5.8 7.9 7.1 5.4 6.6 5.6 11.0 12.2 13.5 13.9
Financial Position:
Fixed Assets (Net)
239 251 243 371 257 250 295 512 379 465
Current Assets, Loans & Advances
344 412 393 504 522 340 408 471 640 774
Current Liabilities & Provisions
83 108 158 183 241 294 400 436 452 732
Net Working Capital 260 304 2353 322 281 46 8 35 189 42
Days of Sales 110 113 78 98 80 14 2 7 33 6
Total Assets
556 609 558 705 640 433 543 624 670 749
Share Capital
29 29 29 29 29 29 29 57 86 86
Reserves & Surplus
233 292 334 365 388 257 335 440 393 531
Shareholders Funds
262 320 362 393 417 286 340 497 480 618
Loan Funds
295 289 196 304 964 132 164 121 160 99
Total Capital Employed
556 609 558 705 640 433 543 624 670 749
Return Ratios:
ROCE (%) 15.1 17.0 19.5 12.6 16.1 28.6 31.3 39.0 45.7 47.7
RONW (%) 19.9 24.7 22.0 16.6 20.6 38.1 46.6 46.1 61.3 55.3
Equity Share Data:
Earnings Per Share (Rs) 17.6 27.1 2.7 2.3 3.0 3.7 31.2 3.7 3.3 3.9
Dividend Per Share (Rs) 5.0 10.0 1.0 0.5 1.4 2.0 2.5 1.8 1.42 1.5
No of  Shares (In Mn) 2.9 2.9 28.5 28.6 28.6 28.6 28.6 57.3 86.3 86.4


         Sales are Gross Sales i.e Net off Sales tax/VAT paid
*       Stock split from Rs 10/share to Rs 1/ share
**     Consolidated results from FY02 onwards
***   Dabur Pharma got de-merged.
#       Bonus issue of 1:1 was issued during the year
^       Bonus Issue of 1:2 was issue during the year